Understanding Leukemias, Lymphomas and MyelomasCRC Press, 13 nov 2013 - 200 páginas A brand-new edition of the bestselling guide to hematologic malignancies.An international team of contributors come together to present all clinically relevant aspects of leukemias, lymphomas, and myelomas. Using clear terminology, the book discusses salient features, diagnostic procedures, prognosis, and treatments for these cancers.Following on t |
Índice
1 Introduction to Blood Cancers | 1 |
2 Myths and Facts About Blood and Stem Cells | 12 |
3 What Happens in Leukemias Lymphomas and Myelomas? | 19 |
4 Different Types of Leukemias Lymphomas and Myelomas | 32 |
5 Diagnosis of Leukemia Lymphoma and Myeloma | 57 |
6 The Patient and the Specialist | 71 |
7 General Management of Blood Cancers | 75 |
8 Specific Therapy for Leukemias | 87 |
10 Specific Current Therapy for Myelomas | 110 |
11 Current Role of Stem Cell Transplantation for Leukemias Lymphomas and Myelomas | 118 |
12 Principal SideEffects of the Treatment of Leukemias Lymphomas and Myelomas | 135 |
13 Future Prospects | 140 |
Glossary | 143 |
Sources of Information and Support for Patients | 152 |
General References and Suggested Further Reading | 156 |
9 Specific Therapy for Lymphomas | 100 |
Otras ediciones - Ver todo
Understanding Leukemias, Lymphomas and Myelomas, Second Edition Tariq I. Mughal No hay ninguna vista previa disponible - 2010 |
Términos y frases comunes
able abnormalities achieve activity acute adults agents allogeneic SCT appears associated autologous B-cell B-cell lymphoma blood cells bone marrow called cancer cancer cells cause chemotherapy chromosome chronic clinical combination complete condition counts cytoplasm develop diagnosis discuss disease donor dose drug effective efforts example factors Figure further gene genetic growth imatinib immune important improve increased individual infection involved known less lymph node lymphoblastic lymphocytes lymphoma major molecular months myeloid leukemia myeloma normal occur particular patients phase photomicrograph plasma possible potential present produce prognostic progress protein radiotherapy rare rates receiving recent relapse remains remission reported require response risk role showing skin Source specialists specific stage stem cell stem cell transplant studies subtype suggest syndrome term tests therapy tion transplant treated treatment trials tumor United usually vincristine